Yinghua Lang

Statistics

Publications

Citations

3.6K

H-Index

Active since

2009

Affiliations

University of California San Diego(Current)

Western University

Universitair Ziekenhuis Leuven

Robarts Clinical Trials

Icahn School of Medicine at Mount Sinai

Yinghua Lang is an author at University of California San Diego specializing in inflammatory bowel disease therapy, crohn disease pharmacotherapy, and inflammation.

ORCID

Publications per year

2009–2018

Publications

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Brian G. Feagan, William J. Sandborn, Christopher Gasink et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Jean‐Frédéric Colombel, Paul Rutgeerts, Walter Reinisch et al. · Gastroenterology · 2011 · 919 citations · Full text

Veterinary Medicine, Immunology, Immunotherapy +16

Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies

Walter Reinisch, William J. Sandborn, Paul Rutgeerts et al. · Inflammatory Bowel Diseases · 2011 · 208 citations

Pharmacy, Internal Medicine, Pharmacotherapy +15

Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD‐subgroup analyses across four randomized trials

Gary Lichtenstein, Robert H. Diamond, Carrie Wagner et al. · Alimentary Pharmacology & Therapeutics · 2009 · 193 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease

Paul Rutgeerts, Christopher Gasink, Daphne Chan et al. · Gastroenterology · 2018 · 179 citations

Medicine, Clinical Sciences, Internal Medicine +14

1–5 of 11